Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Chinese Patent Office
Teva
Colorcon
Cipla
Chubb
Dow
Johnson and Johnson

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,217,974

« Back to Dashboard

Summary for Patent: 5,217,974
Title: Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
Abstract:Administration of a folate binding protein binding agent in conjunction with use of an antitumor agent which is an inhibitor of glycinamide ribonucleotide transformylase or other antifolate reduces the toxic effects of such agent and provides an enhanced therapeutic index.
Inventor(s): Grindey; Gerald B. (Indianapolis, IN), Shih; Chuan (Carmel, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:07/940,568
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,217,974

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,217,974

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 126700 ➤ Try a Free Trial
Australia 640524 ➤ Try a Free Trial
Australia 8457091 ➤ Try a Free Trial
Canada 2051520 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Baxter
Fuji
QuintilesIMS
Express Scripts
Dow
Chubb
Federal Trade Commission
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.